Cargando…

MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy

BACKGROUND: The study was undertaken to assess the efficacy of methotrexate (MTX) monotherapy on the radiographic progression of individual rheumatoid arthritis (RA) patients, each of whom had received MTX monotherapy for 3 years with an option to change to biological disease-modifying anti-rheumati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiozawa, Kazuko, Yamane, Takashi, Murata, Miki, Yoshihara, Ryosuke, Tsumiyama, Ken, Imura, Shigeaki, Shiozawa, Shunichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769545/ https://www.ncbi.nlm.nih.gov/pubmed/26922083 http://dx.doi.org/10.1186/s13075-016-0948-7

Ejemplares similares

Self-Organized Criticality Theory and the Expansion of PD-1-Positive Effector CD4 T Cells: Search for Autoantibody-Inducing CD4 T Cells
por: Miyazaki, Yumi, et al.
Publicado: (2013)

Self-Organized Criticality Theory of Autoimmunity
por: Tsumiyama, Ken, et al.
Publicado: (2009)

Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
por: Emery, Paul, et al.
Publicado: (2020)

A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell
por: Hashiramoto, Akira, et al.
Publicado: (2018)

Identification of 7 Proteins in Sera of RA Patients with Potential to Predict ETA/MTX Treatment Response
por: Obry, Antoine, et al.
Publicado: (2015)

ML-13 AN ATTEMPT OF RECHALLENGE OF HD-MTX AND MAINTENANCE THERAPY OF MTX FOR PATIENTS WITH PCNSL
por: Yamaguchi, Takashi, et al.
Publicado: (2019)

Treatment of methotrexate (MTX) intolerance: behavioural therapy, versus switch to parenteral MTX versus oral MTX
por: Verkaaik, M, et al.
Publicado: (2011)

Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients
por: Gosselt, Helen R., et al.
Publicado: (2019)

Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis
por: Katchamart, W, et al.
Publicado: (2008)

DOCK8-expressing T follicular helper cells newly generated beyond self-organized criticality cause systemic lupus erythematosus
por: Shiozawa, Shunichi, et al.
Publicado: (2021)

Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy
por: Zhang, Jing, et al.
Publicado: (2020)

Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX
por: Hider, S. L., et al.
Publicado: (2008)

Pro-MMP levels and severity of RA
por: Tchetverikov, I, et al.
Publicado: (2003)

Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
por: Affleck, K., et al.
Publicado: (1992)

Impairment of Methotrexate (MTX)‐Polyglutamate Formation of MTX‐resistant K562 Cell Lines
por: Koizumi, Shoichi
Publicado: (1988)

Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World
por: Zhang, Le, et al.
Publicado: (2020)

Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
por: Müller, Sabrina, et al.
Publicado: (2017)

Complete Remission of Colon Cancer with Ipilimumab Monotherapy
por: Suzuki, Sho, et al.
Publicado: (2020)

Endoscopic Ultrasonic Aspiration of Superficial Bladder Tumors
por: Miki, Makoto, et al.
Publicado: (1995)

Implementation of an Outpatient HD-MTX Initiative
por: Sokol, Kelsey, et al.
Publicado: (2022)

Epidemiological Study Regarding the Incidence of Venous Thromboembolism in Patients After Cancer Remission
por: Imura, Miki, et al.
Publicado: (2022)

Cost-effectiveness model for a hypothetical monotherapy vs standard of care in adult patients with treatment-resistant depression
por: Wang, Si-Tien, et al.
Publicado: (2019)

How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy
por: Taylor, Peter. C., et al.
Publicado: (2019)

Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration
por: Takemori, Nobuo, et al.
Publicado: (2012)

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
por: Harrold, Leslie R., et al.
Publicado: (2017)

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
por: Vieira-Sousa, Elsa, et al.
Publicado: (2020)

Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis
por: Fleischmann, Roy, et al.
Publicado: (2016)

Monitoring Of High-Dose Methotrexate (Mtx)-Related Toxicity and Mtx Levels in Children with Acute Lymphoblastic Leukemia: A Pilot-Study in Indonesia
por: Sari, Nur Melani, et al.
Publicado: (2021)

Clinical characteristics of pneumoperitoneum with pneumatosis intestinalis detected using computed tomography: A descriptive study
por: Adachi, Wataru, et al.
Publicado: (2020)

Complete Genome Sequence of Serratia marcescens Phage MTx
por: Graham, Kristin, et al.
Publicado: (2019)

Effect of antioxidant activity of caffeic acid with cyclodextrins using ground mixture method
por: Shiozawa, Ryota, et al.
Publicado: (2018)

Predicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
por: Collins, Jamie E., et al.
Publicado: (2020)

Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
por: Benson, Rosalind, et al.
Publicado: (2020)

Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort
por: Sewerin, Philipp, et al.
Publicado: (2017)

Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis
por: Matsuno, Osamu, et al.
Publicado: (2022)

Advanced gastric cancer showing long-term complete remission in response to S-1 monotherapy: two case reports
por: Mitomi, Hiroyuki, et al.
Publicado: (2008)

Improvement of T-cell function in rheumatoid arthritis (RA) patients in clinical remission is associated with the recovery of IL-7 expression and depends on a familial history of RA
por: Ponchel, F, et al.
Publicado: (2005)

Fusion of the Dhfr/Mtx and IR/MAR Gene Amplification Methods Produces a Rapid and Efficient Method for Stable Recombinant Protein Production
por: Noguchi, Chiemi, et al.
Publicado: (2012)

Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis
por: Chara, Luis, et al.
Publicado: (2012)

Serious infections in JIA patients upon MTX, TFN inhibitors and combinations
por: Horneff, Gerd, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bhmo9or320htvloqvl3fbtvdtb